Extracellular vesicles in atherosclerosis.

Extracellular vesicles (EVs), which exist in human blood, are increased in some inflammation-related cardiovascular diseases. EVs are involved in inflammation, immunity, signal transduction, cell survival and apoptosis, angiogenesis, thrombosis, and autophagy, all of which are highly significant for maintaining homeostasis and disease progression. Therefore, EVs are also associated with key steps in atherosclerosis, including cellular lipid metabolism, endothelial dysfunction and vascular wall inflammation, ultimately resulting in vascular remodelling. In this review, we summarize recent studies on EV contents and biological function, focusing on their potential effect in atherosclerosis, including cholesterol metabolism, vascular inflammation, angiogenesis, coagulation and the development of atherosclerotic lesions. EVs may represent potential biomarkers and pharmacological targets for atherosclerotic diseases. • EVs involve in inflammation, immunity, signal transduction, cell apoptosis, angiogenesis, thrombosis, and autophagy. • EVs are associated with the key steps of atherosclerosis, and ultimately resulting in vascular remodelling. • EV may be as potential biomarkers and pharmacological targets for atherosclerotic diseases. [ABSTRACT FROM AUTHOR]